三達膜(688101.SH)澄清:2020年鹽湖提鋰業務收入佔比小 與青海國安並無業務往來
格隆匯7月13日丨三達膜(688101.SH)發佈關於媒體對鹽湖提鋰業務報道的澄清説明公吿,公司鹽湖提鋰業務在手訂單金額為1073萬元,收款金額為362萬元;在2020年,公司鹽湖提鋰業務收入佔公司營業總收入的比例為0.4%。公司與青海國安自2020年無業務往來,並非媒體報道中提及的青海中信國安鋰業發展有限公司為公司的主要客户。
公司的主營業務為膜技術應用方案提供商和水務投資運營商,主要涉及工業材液分離,產品分離純化、廢水資源化、飲用水安全保障等領域。鹽湖提鋰業務的營業收入所佔公司營業收入的比例較小,並非公司的核心業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.